Industry Insight: Psychedelic Patent Activity & Key Filers in 2025

This report from Psychedelic Alpha details the significant intellectual property (IP) activity in the psychedelic space during 2025, tracking nearly 1,500 U.S. patents and applications, including neuroplastogens. It identifies top filers like CaaMTech, GH Research, and Compass Pathways, indicating a maturing IP landscape.

The Q1 2026 update from Psychedelic Alpha, published April 10, 2026, provides an analysis of the evolving psychedelic intellectual property (IP) landscape. In 2025, the database expanded significantly, tracking 156 new PCT (Patent Cooperation Treaty) filings and 271 new U.S. patent applications. During the same period, 122 U.S. patents were issued to companies operating in the psychedelic and neuroplastogen sectors. Noteworthy active filers include CaaMTech, GH Research, Gilgamesh, Atai/Beckley, and Compass Pathways, all with more than a dozen new filings.

Sentinel Insight